Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|September 23, 2016
Antimalarial Activity of KAF156 in Falciparum and Vivax MalariaNicholas J White, Tran T Duong, Chirapong Uthaisin, et al.
NPJ Vaccines|July 6, 2024
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adultsBorimas Hanboonkunupakarn, Mavuto Mukaka, Podjanee Jittamala, et al.
Human Vaccines & Immunotherapeutics|July 16, 2019
Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteersLorenz von Seidlein, Borimas Hanboonkunupakarn, Podjanee Jittamala, et al.
The Lancet. Infectious Diseases|July 28, 2026
Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trialPodjanee Jittamala, William H K Schilling, Stije J Leopold, et al.
The Lancet. Infectious Diseases|April 27, 2024
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)Phrutsamon Wongnak, William H K Schilling, Podjanee Jittamala, et al.
Communications Biology|March 29, 2022
Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional responseLei Zhu, Rob W van der Pluijm, Michal Kucharski, et al.
Plos Neglected Tropical Diseases|January 6, 2023
Correction: A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?Podjanee Jittamala, Wuelton Monteiro, Menno R Smit, et al.
Elife|February 21, 2023
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)William H K Schilling, Podjanee Jittamala, James A Watson, et al.
The Lancet. Infectious Diseases|October 13, 2025
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trialWilliam H K Schilling, Podjanee Jittamala, Phrutsamon Wongnak, et al.
Plos Neglected Tropical Diseases|March 17, 2021
A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?Podjanee Jittamala, Wuelton Monteiro, Menno R Smit, et al.
Pageof 6